Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation

Ítems similars

• Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
  per: Morra, Enrica, et al.
  Publicat: (2009)
• Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements: author reply
  per: Angelucci, Emanuele, et al.
  Publicat: (2009)
• Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up
  per: Brusamolino, Ercole, et al.
  Publicat: (2009)
• Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study
  per: Rosti, Giovanni, et al.
  Publicat: (2016)
• Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars
  per: Perrone, Valentina, et al.
  Publicat: (2016)